GMMG- HD9

Section NCT
Category Hematological neoplasms
Subcategory Multiple myeloma
Trial Type First-Line-Therapy (Metastatic Disease/Hematology)
Description for experts A randomized phase III trial assessing iberdomide versus iberdomide plus isatuximab maintenance therapy post autologous hematopoietic stem-cell transplantation in patients with newly diagnosed multiple myeloma
Description for laymen A randomized phase III trial assessing iberdomide versus iberdomide plus isatuximab maintenance therapy post autologous hematopoietic stem-cell transplantation in patients with newly diagnosed multiple myeloma
JSON Data { "short_title": "GMMG- HD9", "data_mode": "910", "data_mode_number": "000000058", "official_title": null, "accrual_state": "running", "therapeutic_value": "not_applicable", "therapieansatz_value": "not_applicable", "therapieintervention_value": "not_applicable", "therapielinie_value": "first", "ctgov_number": null, "eudract_number": "2023-507402-13-00", "general_contact_email": "sal-aml-register@ukdd.de", "general_contact_phone": "+49 351-45818380", "hauptpruefer_dd_name": null, "description_laie_de": "Eine randomisierte Phase-III-Studie zur Bewertung von Iberdomid gegen\u00fcber \nErhaltungstherapie mit Iberdomid plus Isatuximab nach autologer h\u00e4matopoetischer Stammzelltransplantation bei \nPatienten mit neu diagnostiziertem multiplem Myelom", "description_laie_en": "A randomized phase III trial assessing iberdomide versus iberdomide plus isatuximab maintenance therapy post autologous hematopoietic stem-cell transplantation in patients with newly diagnosed multiple myeloma", "description_expert_de": "Eine randomisierte Phase-III-Studie zur Bewertung von Iberdomid gegen\u00fcber \nErhaltungstherapie mit Iberdomid plus Isatuximab nach autologer h\u00e4matopoetischer Stammzelltransplantation bei \nPatienten mit neu diagnostiziertem multiplem Myelom", "description_expert_en": "A randomized phase III trial assessing iberdomide versus iberdomide plus isatuximab maintenance therapy post autologous hematopoietic stem-cell transplantation in patients with newly diagnosed multiple myeloma", "rechtsgrundlage_value": null, "phase_amg_value": null, "main_cat_id": 4, "sub_cat_id": 26 }
Settings
Short name 910-000000058